No. Projects aiming to develop new interventions that lack evidence of efficacy or effectiveness, such as instrument development; app development; developing, testing, and validating new decision aids and tools; or clinical prognostication tools will be considered out of scope. The comparison of an evidence-based and/or in widespread use phone app + another evidence-based and/or in widespread use phone app or pharmacological/non-pharmacological intervention may be responsive if applicants can justify the selection of the proposed comparators.
Have more questions? Submit a request